Skip to main content
. Author manuscript; available in PMC: 2011 Apr 13.
Published in final edited form as: Hum Mutat. 2008 Nov;29(11):1282–1291. doi: 10.1002/humu.20880

Table 4.

Testing Recommendations Associated with Each Class of Variant

Class Clinical Testing Surveillance Recommendations if At-Risk Relative is Positive Research Testing of Family Members
5 Test at-risk relatives for variant Full high-risk surveillance guidelines Not indicated
4 Test at-risk relatives for variant* Full high-risk surveillance guidelines May be helpful to further classify variant
3 Do not use for predictive testing in at-risk relatives* Based on family history (and other risk factors) May be helpful to further classify variant
2 Do not use for predictive testing in at-risk relatives* Treat as “no mutation detected” for this disorder May be helpful to further classify variant
1 Do not use for predictive testing in at-risk relatives* Treat as “no mutation detected” for this disorder Not indicated
*

Recommend continuing to test proband for any additional testing modalities available for the disorder in question, e.g. rearrangement testing.